Angiogenesis is the growth of new blood vessels from pre-existing vessels. Reduced angiogenesis contributes to morbidity and mortality in diabetic patients, since it leads to improper wound healing and reduced blood flow to vital organs (Martin, 2003). Extracellular matrix (ECM) degradation is an initial step in angiogenesis, and the plasminogen system is a driving force behind this degradation.

This content is only available via PDF.
You do not currently have access to this content.